• Mashup Score: 5

    Cardiometabolic risk factors and metabolic syndrome continue to be major challenges for health care providers in the United States. Current estimates suggest over a quarter of all US adults have metabolic syndrome, a constellation of cardiometabolic risk factors that includes excessive abdominal fat, insulin resistance, dyslipidemia, and hypertension. These risk factors converge with chronic…

    Tweet Tweets with this article
    • Join me and Dr. Green virtually as we discuss the clinical strategies for evaluation and diagnosis of patients presenting with cardiac, endocrine, and renal disease. Register with my code BAILEY for free registration! https://t.co/2w80TNDiMw #gotoPER #CERC #cardiac https://t.co/sIoEA06r0F

  • Mashup Score: 0

    October 6, 2023 — GE HealthCare announced its Venue Family point-of-care ultrasound systems will now feature Caption Guidance, artificial intelligence (AI)-driven technology that provides real-time guidance to users for capturing diagnostic-quality cardiac images. The Venue Family is the first among GE HealthCare ultrasound products to incorporate this scan guidance technology following the company’s acquisition of Caption Health earlier this year. Caption Guidance is an optional add-on that offers new capabilities at the point of care, supporting clinicians in a wide range of clinical settings and practices such as emergency departments, critical care wards, and anesthesiology. Cardiac ultrasound examinations, which enable examination of the structure of the heart using sound waves, are the primary tool used to help identify heart failure, the most common diagnosis in the U.S. for hospitalized patients over the age of 65. Heart failure contributes to millions of deaths globally every

    Tweet Tweets with this article
    • @DAICeditor @GEHealthCare #AI-powered #technology will expand access to scans by enabling a broader set of #healthcare providers to perform #cardiac exams with real-time guidance at the point of care: https://t.co/cE1tfS2c2B

  • Mashup Score: 0

    The AATS welcomes you to submit your abstracts and case videos to the 104th Annual Meeting. Selected abstracts and videos will be presented in-person April 27-30, 2024 in Toronto. Waiver of mandatory manuscript submission for publication in JTCVS may be requested at the time of submission. The requirement for manuscript submission to the JTCVS does not apply to Abstracts for the C. Walton Lillehei Resident Forum, posters, or case videos. Click on a category for more information. Clinical and translational

    Tweet Tweets with this article
    • New #AATS2024 submission category: Structural Heart abstracts. We're now accepting research on multivalve diseases, left atrial appendage occlusion, and more. Submit by 10/16 (only two weeks away): https://t.co/yTUQ34gY9I #Cardiac #CardiacTwitter #CardiacSurgery #MedTwitter https://t.co/hk3Z6f7hKW

  • Mashup Score: 0

    At the Forefront of Cardiothoracic Surgery, AATS members have a proven record of distinction within the specialty and have made significant contributions to the care and treatment of cardiothoracic disease.

    Tweet Tweets with this article
    • October's first global grand rounds webinar is Wednesday, 10/4. Join us at 8am ET for a discussion on Cerebral Malperfusion in Acute Type A Dissection. Register now: https://t.co/FXI469LA5e @StanfordCTSurg @estrera_md @TheAortologist #Cardiac #CardiacTwitter #MedTwitter https://t.co/0Dk5CdrFRK

  • Mashup Score: 0

    -RESUScitation Project (NCT02837497, 2016–2021). Setting: Eighteen PICUs. Patients: Children less than or equal to 18 years old and greater than or equal to 37 weeks postconceptual age receiving chest compressions (CC) of any duration during the study. Interventions: None Measurements and Main Results: Of 1,100 children with IHCA, there were 273 medical cardiac (25%), 383 surgical cardiac (35%), and 444 noncardiac (40%) cases. Favorable neurologic outcome was defined as no more than moderate disability or no worsening from baseline Pediatric Cerebral Performance Category at discharge. The medical cardiac group had lower odds of survival with favorable neurologic outcomes compared with the noncardiac group (48% vs 55%; adjusted odds ratio [aOR] [95% CI], aOR 0.59 [95% CI, 0.39–0.87], p = 0.008) and surgical cardiac group (48% vs 58%; aOR 0.64 [95% CI, 0.45–0.9], p = 0.01). We failed to identify a difference in favorable outcomes between surgical cardiac and noncardiac groups. We also fa

    Tweet Tweets with this article
    • Survival With Favorable Neurologic Outcome and Quality of #CPR following #IHCA in kids with #Cardiac v NonCardiac #PedsICU #PedsCICU #ICURESUS @PedCritCareMed https://t.co/TceL12WrfM

  • Mashup Score: 0

    September 27, 2023 — HeartBeam, Inc., a Santa Clara, CA-based cardiac technology company, has appointed Richa Gujarati as Senior Vice President, Product, and Pooja Chatterjee as Vice President, Clinical. Gujarati will have direct responsibility for product roadmap and go-to-market strategy and execution at HeartBeam. Chatterjee will be responsible for strategic and tactical leadership of the clinical pipeline, with the objective of securing FDA clearances to support commercialization. According to a statement announcing the senior management team appointments, the company has developed the first and only credit card-size 3D-vector electrocardiogram (VECG) platform for patient use at home, allowing for the creation of rich data for artificial intelligence (AI). Richa Gujarati has over 13 years of experience collecting market-level insights and translating them into business needs, driving overall product portfolio and go-to-market strategy. Prior to joining HeartBeam, Richa was Vice Pre

    Tweet Tweets with this article
    • @DAICeditor @HeartBeamInc #Cardiac #technology company #HeartBeam has announced senior management appointments to support its 3D-vector #electrocardiogram (#VECG) platform technology: https://t.co/2sTV0YrVAm

  • Mashup Score: 0

    September 25, 2023 —  After world’s first successful transplant in 2022, also performed at the University of Maryland Medical Center (UMMC), this groundbreaking transplant team performed second pig heart transplant on patient deemed ineligible for traditional heart transplant.  A 58-year-old patient with terminal heart disease became the second patient in the world to receive a historic transplant of a genetically-modified pig heart on September 20. He is recovering and communicating with his loved ones. This is only the second time in the world that a genetically modified pig heart has been transplanted into a living patient.  Both historic surgeries were performed by University of Maryland School of Medicine (UMSOM) faculty at the University of Maryland Medical Center (UMMC).  The first historic surgery, performed in January, 2022, was conducted on David Bennett by University of Maryland Medicine surgeons (comprising UMSOM and UMMC), who are recognized as the leaders in cardiac xenot

    Tweet Tweets with this article
    • @DAICeditor @UMmedschool Landmark #cardiac #xenotransplantation procedure conducted at University of Maryland Medical Center: https://t.co/cXPNjKy2Cp #pigheart @artificialheart #transplant